China Medical System Holdings Limited (HKG:0867)
Hong Kong
· Delayed Price · Currency is HKD 8.18
+0.07 (0.86%)
Apr 29, 2025, 4:08 PM HKT
HKG:0867 Revenue
In the year 2024, China Medical System Holdings had annual revenue of 7.47B CNY, down -6.79%. China Medical System Holdings had revenue of 3.86B in the half year ending December 31, 2024, a decrease of -17.96%.
Revenue
7.47B CNY
Revenue Growth
-6.79%
P/S Ratio
2.47
Revenue / Employee
1.22M CNY
Employees
6,141
Market Cap
19.60B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.47B | -544.30M | -6.79% |
| Dec 31, 2023 | 8.01B | -1.14B | -12.43% |
| Dec 31, 2022 | 9.15B | 813.13M | 9.75% |
| Dec 31, 2021 | 8.34B | 1.39B | 20.03% |
| Dec 31, 2020 | 6.95B | 872.34M | 14.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |
China Medical System Holdings News
- 3 months ago - Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China - Benzinga